A high-integrity, easy-to-read, print-friendly page for clinic teams: accurate measurement, simple stages, and a clear rule for action when BP is 140/90 or higher. Gentle Valentine's vibes included. No fluff.
You cannot treat what you did not measure correctly. These steps are not "nice to have" - they can change BP a lot.
Measurement tips are summarized from American Heart Association patient and clinical education materials and the AHA scientific statement on BP measurement (see references).
One look. No ambiguity. Use systolic or diastolic (whichever is higher category).
| Category | Systolic | Diastolic |
|---|---|---|
| Normal | <120 | <80 |
| Elevated | 120-129 | <80 |
| Stage 1 HTN | 130-139 | 80-89 |
| Stage 2 HTN | 140 or higher | 90 or higher |
| Severe | Higher than 180 | And/or higher than 120 |
These cut points match American Heart Association educational materials and the ACC/AHA classification framework (see references).
Use the average of correctly measured readings and confirm outside the office when appropriate. Start medication for average BP at least 140/90, and for selected adults at least 130/80 based on cardiovascular disease, stroke, diabetes, chronic kidney disease, or PREVENT risk.
- Confirm measurement was done correctly (2 readings, 1 minute apart).
- Document assessment: uncontrolled HTN (or suspected white-coat, etc).
- Do something measurable: med adjustment, start meds, reinforce lifestyle, evaluate adherence, remove blockers.
- Arrange follow-up and data: home BP log or device memory upload.
- Provider visit within 1 month for stage 2 HTN (guideline standard).
- Nurse BP check visit (with medication protocol if available).
- Virtual visit (video or phone) focused on BP and adherence.
- At minimum: home BP checks with 2 readings, 1 minute apart, and report results promptly.
The 2025 AHA/ACC overarching treatment goal is below 130/80 mm Hg for adults. Individualize decisions for institutional care, limited life expectancy, pregnancy, symptomatic orthostasis, and other clinical circumstances.
Goal concept: below 130/80 mm Hg for adults, using averaged, correctly measured readings.
Clinic behavior: confirm readings, assess cardiovascular risk and comorbidities, and document medication, lifestyle, monitoring, and follow-up decisions.
Examples: age 80+ with symptomatic orthostasis, moderate-to-severe frailty, multimorbidity, or limited lifespan.
Examples of vetted targets: some guidance uses clinic target under 150/90 for age 80+ and bases targets on standing BP if postural hypotension is present.
Example exception targets come from NICE NG136 and European guidance that provides age- and frailty-sensitive targets (see references).
This is why we care enough to do the measurement right and act when BP is 140/90 or higher. Large trials show meaningful reductions in cardiovascular events and mortality with better BP control in appropriate patients.
Intensive SBP target under 120 vs under 140 reduced major cardiovascular events (hazard ratio 0.75). All-cause mortality also lower (hazard ratio 0.73). Patient selection matters (no diabetes; standardized measurement).
In older adults (60-80), SBP target 110 to under 130 lowered cardiovascular events vs target 130 to under 150.
In adults over 80, BP treatment reduced heart failure by about 64% and reduced all-cause mortality (about 21% in published summaries). Hypertension treatment benefits extend into advanced age.
RCT summary stats are drawn from NEJM and other peer-reviewed summaries (see references). Do not apply intensive targets to non-standardized, rushed readings.
Educational support only. Verify patient-specific decisions against current source guidance and local policy.